solid
14 articles
Bayer's Monsanto unit urged a Missouri judge to approve a $7.25 billion settlement resolving thousands of Roundup cancer lawsuits. The company denies glyphosate causes cancer but seeks to resolve the
Bayer seeks Missouri court approval for a $7.25 billion settlement to resolve tens of thousands of Roundup cancer lawsuits, aiming to conclude years of litigation over the herbicide glyphosate.
Bayer reported an unexpected 1.9% rise in Q2 adjusted profit driven by strong seed technology sales and reduced legal risks from Roundup rulings. The company also lowered its net debt forecast followi
Bayer aims to dismiss nearly 4,000 federal Roundup cancer lawsuits following a U.S. Supreme Court ruling on warning labels, while a separate $7.25 billion state court settlement remains pending for ov
The US Supreme Court ruled that federal law preempts state warning label requirements for Roundup, blocking thousands of lawsuits against Bayer. Despite the victory, Bayer plans to proceed with a prop
The US Supreme Court ruled 7–2 that states cannot mandate additional pesticide warnings beyond EPA approvals under FIFRA. This decision impacts Bayer following a Missouri jury's liability finding rega
Bayer shares surged 17.3%, their biggest jump since 2003, after the U.S. Supreme Court ruled in favor of the company regarding Roundup weedkiller lawsuits. The decision limits thousands of state cases
Bayer confirmed it has no plans to spin off Monsanto despite thousands of Roundup lawsuits. CEO Bill Anderson warned that unresolved glyphosate litigation could halt US production, as the company purs
Bayer plans to oppose transferring its Missouri Roundup class settlement case to a California federal court, insisting the venue should remain in state court. The company stated the transfer order has
The US Supreme Court heard oral arguments in a case concerning Bayer and Monsanto's liability for glyphosate-based Roundup, addressing potential state law warnings for cancer risks absent federal mand
The U.S. Supreme Court hears arguments in Bayer's bid to limit Roundup cancer lawsuits based on federal labeling preemption. A ruling could impact liability for tens of thousands of cases alongside th
Bayer's proposed $7.25 billion settlement for Roundup-related cancer claims received preliminary court approval in Missouri, though the company denies liability. The agreement involves significant pay
Bayer proposes a $7.25 billion Roundup settlement, anticipating €5 billion in litigation payouts in 2026 that will drive negative free cash flow.
Bayer welcomed the U.S. Supreme Court's decision to review its glyphosate litigation appeal, with a ruling expected by June.
ChemBrief